NatWest Group’s iShares Global Healthcare ETF IXJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-4,670
Closed -$285K 79
2019
Q1
$285K Hold
4,670
0.06% 67
2018
Q4
$265K Hold
4,670
0.06% 73
2018
Q3
$294K Hold
4,670
0.05% 71
2018
Q2
$264K Hold
4,670
0.05% 73
2018
Q1
$260K Buy
+4,670
New +$269K 0.06% 75
2017
Q4
Sell
-6,750
Closed -$380K 92
2017
Q3
$380K Sell
6,750
-980
-13% -$53.9K 0.09% 80
2017
Q2
$423K Sell
7,730
-500
-6% -$26.6K 0.1% 79
2017
Q1
$423K Sell
8,230
-2,000
-20% -$100K 0.09% 82
2016
Q4
$485K Buy
+10,230
New +$491K 0.13% 81
2016
Q3
Sell
-7,600
Closed -$384K 131
2016
Q2
$384K Buy
+7,600
New +$379K 0.1% 94

Other funds holding IXJ

NatWest Group's IXJ Position: Q2 2019 in Review

NatWest Group sold out of iShares Global Healthcare ETF (IXJ) in Q2 2019, closing a stake of 4,670 shares — an estimated $285K sold.

NatWest Group first reported a position in IXJ in Q2 2016 and held it in 10 quarters. The position peaked at $485K in Q4 2016. 194 funds tracked by Wall St. Rank hold IXJ as of Q2 2019.

  • NatWest Group reported no remaining iShares Global Healthcare ETF position as of Q2 2019 after selling out during the quarter.
  • NatWest Group sold 4,670 iShares Global Healthcare ETF shares in Q2 2019, an estimated $285K.
  • NatWest Group first reported a position in iShares Global Healthcare ETF in Q2 2016 and held it in 10 quarters.
  • NatWest Group's iShares Global Healthcare ETF position peaked at $485K in Q4 2016.
  • 194 funds tracked by Wall St. Rank held iShares Global Healthcare ETF as of Q2 2019.

Based on NatWest Group's 13F filing for Q2 2019, filed 25 Jul 2019.